Table 1 Study population characteristics
Patients | Episodes | |
|---|---|---|
Total | 75,274 | 132,028 |
Mean age (years) | 40.3 ± 12.0 | |
Sex | ||
Male | 35,103 (46.6%) | |
Female | 40,171 (53.4%) | |
Diagnosis | ||
F20 Schizophrenia | 121,884 (92.3%) | |
F25 Schizoaffective disorder | 10,144 (7.7%) | |
Hospital of discharge | ||
Tertiary | 18,182 (13.8%) | |
General | 19,114 (14.5%) | |
Clinic or other | 94,732 (71.8%) | |
Duration of admission (days) | 40 (24–67) | |
Observation period (days) | 369 (103–1004) | |
Sum of periods (person-years) | ||
All | 255,664 | |
Non-medication | 80,104 | |
Oral alone | 169,948 | |
LAI | 5612 | |
Number of episodes | ||
1 | 47,535 (63.1%) | |
2 | 14,962 (19.9%) | |
3 | 6200 (8.2%) | |
4 or more | 6577 (8.7%) | |
Outcome event | 101,589 (76.9%) | |
Death | 1795 | |
Readmission | 99,794 | |
F20 Schizophrenia | 66,560 (66.7%) | |
F25 Schizoaffective disorder | 5448 (5.5%) | |
F20–29 except F20 and F25 | 1393 (1.4%) | |
F00–F99 except F20-F29 | 5834 (5.8%) | |
Other codes | 20,559 (20.6%) | |